Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Atossa Therapeutics Inc ATOS

Healthcare Biotechnology
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing medicines in areas of significant unmet medical need in oncology with a focus on using (Z)-endoxifen to prevent and treat breast cancer. Its lead drug candidate under development is oral (Z)-endoxifen, which it is developing for both the prevention and treatment of breast cancer. (Z)-endoxifen... see more

Recent & Breaking News (NDAQ:ATOS)

Atossa Genetics to Present at Upcoming Investor Conferences in January 2015

Marketwired January 6, 2015

Atossa Genetics Inc. Provides Update on Pharmacogenetics Testing Now Offered by The National Reference Laboratory for Breast Health, Inc.

Marketwired December 19, 2014

Atossa Genetics Inc. Hires Pieter van der Poel as Vice President of European Commercial Operations

Marketwired December 16, 2014

Atossa Genetics Inc. Announces Successful Closure of FDA Inspections

Marketwired December 5, 2014

Atossa Genetics Inc. Announces Contract With Rhenus Advanced Services B.V.

Marketwired December 2, 2014

Atossa Genetics to Present at Upcoming Investor Conferences and Events in December, 2014

Marketwired November 25, 2014

Atossa Genetics Announces Third Quarter 2014 Financial Results and Provides Company Update

Marketwired November 12, 2014

Atossa Genetics to Announce Third Quarter 2014 Financial Results and Provide a Company Update on Wednesday November 12, 2014

Marketwired November 7, 2014

Atossa Genetics Inc. Wins Dismissal of Securities Class Action Litigation

Marketwired October 31, 2014

Atossa Genetics Receives CE Mark for the ForeCYTE Breast Aspirator Device

Marketwired October 22, 2014

Atossa Genetics to Present at the 13th Annual BIO Investor Forum October 8, 2014

Marketwired October 6, 2014

Atossa Genetics Inc. Provides Regulatory and Commercial Update on Its ForeCYTE Breast Aspirator and Its FullCYTE Breast Aspirator

Marketwired September 23, 2014

Atossa Genetics to Present at Two Upcoming Investor Conferences

Marketwired September 4, 2014

Atossa Genetics Inc. Hires Scott Youmans as Senior Vice President of Operations

Marketwired September 3, 2014

The National Reference Laboratory for Breast Health, Inc., a Wholly Owned Subsidiary of Atossa Genetics, to Exhibit at the 2014 Breast Cancer Symposium, September 4-6, 2014

Marketwired September 2, 2014

Atossa Genetics Announces Commercial Partner for Laboratory Services Offered by The National Reference Laboratory for Breast Health, Inc.

Marketwired August 28, 2014

Atossa Genetics Announces Submission of Additional Information to the FDA in Support of 510(k) for the ForeCYTE Breast Aspirator

Marketwired August 20, 2014

Atossa Genetics Announces Second Quarter 2014 Financial Results and Provides Company Update

Marketwired August 12, 2014

Rodman & Renshaw 2014 Annual Global Investment Conference to be held in New York from September 8 to 10, 2014

Business Wire August 11, 2014

Atossa Genetics to Announce Second Quarter 2014 Financial Results and Provide a Company Update on Tuesday August 12, 2014

Marketwired August 6, 2014